证券代码：688189 证券简称：南新制药 公告编号：2025-029 湖南南新制药股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 1、湖南南新制药股份有限公司（以下简称"公司"）股票交易连续三个交易 日内（2025 年 7 月 28 日、7 月 29 日和 7 月 30 日）收盘价格涨幅偏离值累计达 到 30%，根据《上海证券交易所交易规则》《上海证券交易所科创板股票异常交 易实时监控细则》的有关规定，属于股票交易异常波动的情形。 2、公司近期正在筹划购买某一国内药品技术等资产组事项（以下简称"本 次交易"），尚无法确定是否构成重大资产重组。该事项正处于筹划阶段，尚未签 署任何有关收购的意向协议，是否能够顺利实施存在重大不确定性。公司将根据 该事项的进展情况及时履行信息披露义务，具体内容以公司后续公告为准。敬请 广大投资者理性投资，注意风险。 （一）生产经营情况 3、经公司自查，并向控股股东书面发函查证，公司日常经营情况正常，未 发生重大变化，市场环境或行业政策未发生重大 ...

人民财讯7月30日电，南新制药(688189)7月30日晚间发布股票交易异常波动公告称，近期正在筹划购买 某一国内药品技术等资产组事项，尚无法确定是否构成重大资产重组。该事项正处于筹划阶段，尚未签 署任何有关收购的意向协议，是否能够顺利实施存在重大不确定性。敬请广大投资者理性投资，注意风 险。 ...

南新制药7月30日发布公告，股票交易连续三个交易日内收盘价格涨幅偏离值累计达到30%，属于股票 交易异常波动情形。 经核实，日常经营情况正常，未发生重大变化，市场环境或行业政策未发生重大 调整，内部生产经营秩序正常。近期正在筹划购买某一国内药品技术等资产组事项，尚无法确定是否构 成重大资产重组。截至目前，该事项正处于筹划阶段，公司与相关方尚未签订收购意向书或其他正式协 议，是否能够顺利实施存在重大不确定性。 ...

南新制药：近期正筹划购买某一国内药品技术等资产组事项 尚无法确定是否构成重大资产重组 智通财经7月30日电，南新制药(688189.SH)公告称，公司股票交易连续三个交易日内收盘价格涨幅偏离 值累计达到30%，属于股票交易异常波动的情形。公司近期正在筹划购买某一国内药品技术等资产组事 项（简称"本次交易"），尚无法确定是否构成重大资产重组。该事项正处于筹划阶段，尚未签署任何有 关收购的意向协议，是否能够顺利实施存在重大不确定性。公司将根据该事项的进展情况及时履行信息 披露义务，具体内容以公司后续公告为准。敬请广大投资者理性投资，注意风险。 ...

南新制药发布股票交易异常波动公告，公司股票交易连续三个交易日内(2025年7月28日、7月29日和7月 30日)收盘价格涨幅偏离值累计达到30%，根据相关规定，属于股票交易异常波动的情形。公司近期正 在筹划购买某一国内药品技术等资产组事项，尚无法确定是否构成重大资产重组。该事项正处于筹划阶 段，尚未签署任何有关收购的意向协议，是否能够顺利实施存在重大不确定性。公司将根据该事项的进 展情况及时履行信息披露义务。 ...

科创50指数今日下跌1.11%，报收1058.57点，科创板全日成交量45.71亿股，成交额1630.19亿元，加权 平均换手率为2.52%。 证券时报·数据宝统计显示，今日可交易科创板股中，132只股收盘上涨，涨幅超过10%的有6只，涨幅 在5%至10%的有13只，收盘下跌的有452只，跌幅超10%的有1只。 科创板股换手率区间分布显示，换手率10%~20%的有24只，换手率5%~10%的90只，换手率3%~5%的 130只，换手率1%~3%的295只，换手率不足1%的有50只。 换手率最高的是胜科纳米，该股今日收盘上涨2.30%，全天换手率19.64%，成交额1.81亿元，其次是信 宇人，该股今日收盘下跌7.12%，全天换手率18.89%，成交额3.02亿元，换手率居前的还有南新制药、 益诺思、天承科技等，换手率分别为18.41%、18.08%、18.08%。 市场表现看，换手率超5%的个股中，今日上涨的有53只，涨幅居前的有南新制药、东芯股份、当虹科 技等，分别上涨20.00%、17.33%、15.79%。跌幅居前的有皓元医药、福立旺、仕佳光子等，分别下跌 10.04%、7.72%、7.60%。 分行业 ...

Market Overview - The market showed a mixed performance with the Shanghai Composite Index rising by 0.17% to close at 3615.72 points, while the Shenzhen Component Index fell by 0.77% and the ChiNext Index dropped by 1.62%. The total market turnover exceeded 1.87 trillion yuan [1]. Sector Performance - Major sectors such as banking, insurance, and steel saw a collective rise in the morning but experienced a pullback in the afternoon, narrowing their gains. The three-child policy concept stocks surged in the afternoon, with Beiyinmei (002570) hitting the daily limit within three minutes of trading [3][6]. - The mother and baby concept stocks also showed significant movement, with Beiyinmei closing at 7.39 yuan per share, marking a 9.97% increase [6][9]. - Other sectors like film and television, combustible ice, and innovative drugs remained active, while popular themes such as batteries, digital currencies, and rare earths experienced a collective pullback [3]. Policy Impact on Mother and Baby Sector - The National Health Commission is working on a childcare subsidy system, with an initial budget of approximately 90 billion yuan for this year. This policy is expected to stimulate demand in the mother and baby market, benefiting companies in the milk powder and toy sectors [10]. - Analysts predict that the childcare subsidy plan may boost consumption in the short term and enhance industry expectations in the long term, depending on the progress of supporting policies [10]. Market Size Projections - The Chinese infant and child market is projected to reach 4.2 trillion yuan by 2024 and is expected to exceed 5 trillion yuan by 2025, with a potential to reach 10 trillion yuan by 2030, driven by policy support [11]. Notable Stock Movements - Four leading stocks with market capitalizations exceeding 100 billion yuan had trading volumes over 10 billion yuan, including Northern Rare Earth (143.12 billion yuan), CATL (1.26 trillion yuan), Xinyi Technology (189.15 billion yuan), and Baogang Group (132.24 billion yuan) [13]. - CATL's A-shares fell by 5.05% with a trading volume of 11.71 billion yuan, while its H-shares dropped by 7.66% [15]. Pharmaceutical Sector Activity - The pharmaceutical sector remained active, particularly in innovative drugs, with companies like Nanjing New Pharmaceutical and Chenxin Pharmaceutical hitting their daily limits [17][18]. - The innovative drug industry is entering a phase of "clinical value reassessment," with a shift in valuation logic from storytelling to profitability, indicating long-term investment potential [21]. New Stock Performance - The newly listed stock N Hanhigh saw a dramatic increase of 418.47% on its first trading day, closing at 80 yuan per share after triggering trading halts twice [23].

证券之星消息，7月30日化学制药板块较上一交易日下跌0.01%，昂利康领跌。当日上证指数报收于 3615.72，上涨0.17%。深证成指报收于11203.03，下跌0.77%。化学制药板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 688189 | 南新制药 | 14.28 | 20.00% | 50.53万 | | 6.93亿 | | 688091 | 上海谊众 | 75.40 | 14.68% | 16.63万 | | 12.83亿 | | 000953 | 河化股份 | 8.02 | 10.01% | 49.98万 | | 3.89亿 | | 002675 | 东诚药业 | 17.60 | 10.00% | 21.04万 | | 3.66亿 | | 603367 | 辰欣药业 | 28.52 | 9.99% | 27.34万 | | 7.77亿 | | 605507 | 围邦医药 | 23.68 | 9.99% | 16.00万 | | 3.75亿 | ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 002453 | 华软科技 | 6.22 | 10.09% | 29.86万 | | 1.81亿 | | 688189 | 久日新材 | 25.30 | 7.48% | 16.98万 | | 4.32 Z | | 300637 | 扬帆新材 | 12.39 | 5.90% | 26.95万 | | 3.27亿 | | 688157 | 松井股份 | 35.47 | 5.19% | 7.72万 | | 2.75亿 | | 688269 | 凯立新材 | 36.40 | 4.87% | 6.22万 | | 2.27亿 | | 600873 | 梅化生物 | 11.65 | 3.65% | 46.56万 | | 5.40亿 | | 301077 | 星华新材 | 22.14 | 3.55% | 7.32万 | | 1.60亿 | | 688625 | 呈和科技 | 32.26 | 3.17% | 3.73万 | | 1.20亿 | | 6 ...

Market Overview - The three major A-share indices showed mixed performance on the morning of the 30th, with the Shanghai Composite Index rising by 0.52%, while the Shenzhen Component Index and the ChiNext Index fell by 0.06% and 0.71% respectively [2] - The total trading volume in the Shanghai and Shenzhen markets reached 1,102.2 billion yuan, a decrease of 43.6 billion yuan compared to the previous day [2] Sector Performance - The innovative drug and film industry sectors experienced gains, with stocks such as Nanjing New Pharmaceutical and Happiness Blue Sea hitting the daily limit of 20% [2] - The battery sector faced adjustments, with companies like Xinyu Ren and Zhengye Technology dropping over 5% [2] - The digital currency sector weakened, with Dongxin Peace falling more than 8% [2] - The diversified financial sector also saw fluctuations, with companies like Nanhua Futures and Zhongyou Capital declining over 5% [2]